CI vs ISPC
Cigna Corp (CI) versus iSpecimen Inc (ISPC) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. ISPC currently screens at market cap $4.4M.
Not investment advice. Open the CI and ISPC stock pages for the full models.
Not investment advice.